Engineers at the McKelvey School of Engineering at Washington University in St. Louis have received federal funding for a rapid COVID-19 test using a newly developed technology called plasmonic-fluor.
The test is based on a new biolabeling technology called plasmonic-fluor
Engineers at the McKelvey School of Engineering at Washington University in St. Louis have received federal funding for a rapid COVID-19 test using a newly developed technology.
Srikanth Singamaneni, professor of mechanical engineering and materials science, and his team have developed a rapid, highly sensitive and accurate biosensor based on an ultrabright fluorescent nanoprobe, which has the potential to be broadly deployed.
Called plasmonic-fluor, the ultrabright fluorescent nanoprobe can also help in resource-limited conditions because it requires fewer complex instruments to read the results. The National Science Foundation has awarded Singamaneni and his team a $100,008 grant toward developing a COVID-19 test using plasmonic-fluor.
Singamaneni hypothesizes their plasmonic-fluor-based biosensor will be 100 times more sensitive compared with the conventional SARS-CoV-2 antibody detection method. Increased sensitivity would allow clinicians and researchers to more easily find positive cases and lessen the chance of false negatives.
Plasmonic-fluor works by increasing the fluorescence signal to background noise. Imagine trying to catch fireflies outside on a sunny day. You might net one or two, but against the glare of the sun, those little buggers are difficult to see. What if those fireflies had the similar brightness as a high-powered flashlight?
Plasmonic-fluor effectively turns up the brightness of fluorescent labels used in a variety of biosensing and bioimaging methods. In addition to COVID-19 testing, it could potentially be used to diagnose, for instance, that a person has had a heart attack by measuring the levels of relevant molecules in blood or urine samples.
Using plasmonic-fluor, which is composed of gold nanoparticles coated with conventional dyes, researchers have been able to achieve up to a 6,700-fold brighter fluorescent nanolabel compared with conventional dyes, which can potentially lead to early diagnosis. Using this nanolabel as an ultrabright flashlight, they have demonstrated the detection of extremely small amounts of target biomolecules in biofluids and even molecules present on the cells.
The study was published in the April 20 issue of Nature Biomedical Engineering.
Gold nanoparticles serve as beacons
In biomedical research and clinical labs, fluorescence is used as a beacon to see and follow target biomolecules with precision. It’s an extremely useful tool, but it’s not perfect.
“The problem in fluorescence is, in a lot of cases, it’s not sufficiently intense,” Singamaneni said. If the fluorescent signal isn’t strong enough to stand out against background signals, just like fireflies against the glare of the sun, researchers may miss seeing something less abundant but important.
“Increasing the brightness of a nanolabel is extremely challenging,” said Jingyi Luan, lead author of the paper. But here, it’s the gold nanoparticle sitting at the center of the plasmonic-fluor that really does the work of efficiently turning the fireflies into flashlights, so to speak. The gold nanoparticle acts as an antenna, strongly absorbing and scattering light. That highly concentrated light is funneled into the fluorophore placed around the nanoparticle. In addition to concentering the light, the nanoparticles speed up the emission rate of the fluorophores. Taken together, these two effects increase the fluorescence emission.
Essentially, each fluorophore becomes a more efficient beacon, and the 200 fluorophores sitting around the nanoparticle emit a signal that is equal to 6,700 fluorophores.
In addition to detecting low quantities of molecules, sensing time can be shortened using plasmonic-fluor as brighter beacons mean fewer captured proteins are needed to determine their presence.
The researchers have also shown that plasmonic-fluor allows the detection of multiple proteins simultaneously. And in flow cytometry, plasmonic-fluor’s brightening effect allows for a more precise and sensitive measurement of proteins on cell surface, whose signal may have been buried in the background noise using traditional fluorescent tagging.
There have been other efforts to enhance fluorescent tagging in imaging, but many require the use of an entirely new workflow and measurement platform. In addition to plasmonic-fluor’s ability to greatly increase the sensitivity and decrease the sensing time, it doesn’t require any changes to existing laboratory tools or techniques.
The technology has been licensed to Auragent Bioscience LLC by Washington University’s Office of Technology Management. Auragent is in the process of further development and scaling up the production of plasmonic-fluors for commercialization.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Plasmonic-fluor
- Fluor Q3 Results Show Earnings 45% Above Market Predictions
Image: Fluor Corp. November 22, 2023 Fluor Corp. surprised and pleased market analysts with better-than-expected third-quarter earnings and revenue results revealed earlier this month.
- Analyst Ratings for Fluor
Fluor (NYSE:FLR) has observed the following analyst ratings within the last quarter: In the last 3 months, 4 analysts have offered 12-month price targets for Fluor. The company has an average ...
- Fluor to Participate in Upcoming Investor Conferences
IRVING, Texas, November 06, 2023--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) today announced that management will be participating in the following investor conferences: Baird Global ...
- Fluor Earnings: Strong Backlog and Prospect Pipeline Position Firm Well for Continued Growth
We’ve raised our fair value estimate for Fluor FLR to $37.50 from $36 after the engineering and construction firm reported solid third-quarter results and increased its full-year outlook for the ...
- Fluor Corporation (NYSE:FLR) Q3 2023 Earnings Call Transcript
Fluor Corporation (NYSE:FLR) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good morning and welcome to Fluor's Third Quarter 2023 Earnings Conference Call. Today's call is being ...
Go deeper with Google Headlines on:
Plasmonic-fluor
[google_news title=”” keyword=”plasmonic fluor” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Rapid COVID-19 test
- COVID-19 rapid tests now available without appointment at some N.B. sites
Free COVID-19 rapid test kits are a bit easier to acquire in New Brunswick now that the Department of Health has dropped the requirement for pickup appointments at some locations.
- Province says it has plenty of COVID tests
The provincial government has reassured Manitobans it has an abundant supply of rapid tests just as the number of COVID-19 outbreaks at personal care homes has jumped and hospital admissions have ...
- The best at-home COVID-19 test for 2023
With so many At-home Covid rapid testing options on the market, figuring out which COVID test is right for you can be hard, here's what our experts and researchers had to say.
- More free COVID-19 test kits available through USPS starting Nov. 20
Beginning Nov. 20, households that ordered COVID tests this fall may request four more. Anyone who did not order tests this fall may place 2 orders.
- Nearly 40 million rapid COVID tests unused in Alberta as expiry dates loom
"Results of an expired test may not always be accurate. It is recommended that people use unexpired tests and follow the provided instructions carefully." Alberta's COVID-19 rapid antigen tests ...
Go deeper with Google Headlines on:
Rapid COVID-19 test
[google_news title=”” keyword=”rapid COVID-19 test” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]